Literature DB >> 28637652

GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.

Ana Lukic1, Pia Larssen2, Alexander Fauland1, Bengt Samuelsson1, Craig E Wheelock1, Susanne Gabrielsson2, Olof Radmark3.   

Abstract

M1 and M2 activated macrophages (Mϕs) have different roles in inflammation. Because pathogens may first encounter resting cells, we investigated lipid mediator profiles prior to full activation. Human monocytes were differentiated with granulocyte Mϕ colony-stimulating factor (GM-CSF) or Mϕ colony-stimulating factor (M-CSF), which are known to prime toward M1 or M2 phenotypes, respectively. Lipid mediators released during resting conditions and produced in response to bacterial stimuli (LPS/N-formylmethionyl-leucyl-phenylalanine or peptidoglycan) were quantified by liquid chromatography-mass spectrometry. In resting conditions, both Mϕ phenotypes released primarily proresolving lipid mediators (prostaglandin E2 metabolite, lipoxin A4, and 18-hydroxyeicosapentaenoic acid). A striking shift toward proinflammatory eicosanoids was observed when the same cells were exposed (30 min) to bacterial stimuli: M-CSF Mϕs produced considerably more 5-lipoxygenase products, particularly leukotriene C4, potentially linked to M2 functions in asthma. Prostaglandins were formed by both Mϕ types. In the M-CSF cells, there was also an enhanced release of arachidonic acid and activation of cytosolic phospholipase A2 However, GM-CSF cells expressed higher levels of 5-lipoxygenase and 5-lipoxygenase-activating protein, and in ionophore incubations these cells also produced the highest levels of 5-hydroxyeicosatetraenoic acid. In summary, GM-CSF and M-CSF Mϕs displayed similar proresolving lipid mediator formation in resting conditions but shifted toward different proinflammatory eicosanoids upon bacterial stimuli. This demonstrates that preference for specific eicosanoid pathways is primed by CSFs before full M1/M2 activation.-Lukic, A., Larssen, P., Fauland, A., Samuelsson, B., Wheelock, C. E., Gabrielsson, S., Radmark, O. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures. © FASEB.

Entities:  

Keywords:  M1; M2; eicosanoid; leukotriene; lipoxin

Mesh:

Substances:

Year:  2017        PMID: 28637652     DOI: 10.1096/fj.201700319R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  The transition of M-CSF-derived human macrophages to a growth-promoting phenotype.

Authors:  Kajal Hamidzadeh; Ashton T Belew; Najib M El-Sayed; David M Mosser
Journal:  Blood Adv       Date:  2020-11-10

Review 2.  Dendritic Cell-Targeted Therapies to Treat Neurological Disorders.

Authors:  Asim Hussain; Hamza Rafeeq; Nimra Munir; Zara Jabeen; Nadia Afsheen; Khalil Ur Rehman; Muhammad Bilal; Hafiz M N Iqbal
Journal:  Mol Neurobiol       Date:  2021-11-06       Impact factor: 5.590

Review 3.  Leukotriene biosynthetic enzymes as therapeutic targets.

Authors:  Jesper Z Haeggström
Journal:  J Clin Invest       Date:  2018-07-02       Impact factor: 14.808

4.  Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria.

Authors:  Samer Bazzi; Emale El-Darzi; Tina McDowell; Helmout Modjtahedi; Satvinder Mudan; Marcel Achkar; Charles Akle; Humam Kadara; Georges M Bahr
Journal:  Front Immunol       Date:  2017-10-03       Impact factor: 7.561

5.  GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization.

Authors:  E Scott Halstead; Todd M Umstead; Michael L Davies; Yuka Imamura Kawasawa; Patricia Silveyra; Judie Howyrlak; Linlin Yang; Weichao Guo; Sanmei Hu; Eranda Kurundu Hewage; Zissis C Chroneos
Journal:  Respir Res       Date:  2018-01-05

Review 6.  Eicosanoid Control Over Antigen Presenting Cells in Asthma.

Authors:  Nincy Debeuf; Bart N Lambrecht
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

7.  M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations.

Authors:  Alexandra Nikonova; Musa Khaitov; David J Jackson; Stephanie Traub; Maria-Belen Trujillo-Torralbo; Dmitriy A Kudlay; Anton S Dvornikov; Ajerico Del-Rosario; Rudolf Valenta; Luminita A Stanciu; Rahim Khaitov; Sebastian L Johnston
Journal:  EBioMedicine       Date:  2020-04-09       Impact factor: 8.143

8.  A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.

Authors:  Yannick van Sleen; William F Jiemy; Sarah Pringle; Kornelis S M van der Geest; Wayel H Abdulahad; Maria Sandovici; Elisabeth Brouwer; Peter Heeringa; Annemieke M H Boots
Journal:  Arthritis Rheumatol       Date:  2021-11-01       Impact factor: 15.483

Review 9.  Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review.

Authors:  Undurti N Das
Journal:  J Adv Res       Date:  2018-01-03       Impact factor: 10.479

10.  Dicer up-regulation by inhibition of specific proteolysis in differentiating monocytic cells.

Authors:  Devaraj Basavarajappa; Stella Uebbing; Marius Kreiss; Ana Lukic; Beatrix Suess; Dieter Steinhilber; Bengt Samuelsson; Olof Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.